Gingival recession coverage, gain of keratinized tissue, soft tissue ridge augmentation, exposed root coverage, filling of defects after the removal of cysts, soft tissue grafting with GBR/GTR technique
DSI Zenoss Matrix Bio+ is a natural acellular membrane matrix engineered from highly purified collagen that offers a safe alternative to autologous tissue transplantation. Fully resorbable with a sustained resorption time of 5 to 6 months. Guides the healing and regeneration of bone and surrounding tissue. Unique fiber orientation provides high tensile strength for in situ stability of membrane cell occlusive, designed to prevent epithelium down growth.
DSI Zenoss Matrix Bio+ supports revascularization, and fast soft tissue integration and is a valid alternative for patients' own soft or connective tissue grafts. It is cleaned by a special method that eliminates all possible elements that may cause rejection of the human body.
DSI Zenoss Matrix Bio+ is non-immunogenic and inert, delivering a complete absence of a pronounced inflammatory response. The membrane is not antigenic and is highly biocompatible. It prevents the proliferation and migration of the epithelium and creates optimal conditions for GBR procedures. It can be highly hydrated and moisten rapidly which allows excellent tissue adherence and better wound healing. It will hold the blood clot without structural changes.
Indications:
Gingival recession coverage
Gain of keratinized tissue
Soft tissue ridge augmentation
Exposed root coverage
Filling of defects after the removal of cysts
Soft tissue grafting with GBR/GTR technique
As a stabilizer of the clot
DSI Zenoss Matrix Bio+ is also available in a plug form, making it ideal to use in post-extraction sites
Features:
Natural collagen matrix.
Rapid rehydration.
Easy handling, application, and fixation.
Complete remodeling into patient‘s own tissue in 3-6 months.
Soft tissue graft without the need for autograft harvesting.
Longer resorption time, for sustained function in bone repair.
Higher mechanical strength for membrane stabilization.
Each piece can be easily trimmed during surgery for a final fit.
May be placed on either side against the tissue or bone.
Highly purified collagen is derived from bovine tissue.
High in mechanical strength and structural integrity for easy handling.
Highly biocompatible.
Permeable to macromolecules and nutrients while creating an effective barrier to epithelial cells.
Conformable and repositionable for precise adjustment and placement.
Terminally sterilized and ready for use following brief hydration.
How to use:
1. The general principles of sterile handling and patient medication must be followed when using the Zenoss Matrix. 2. After opening, Zenoss Matrix is trimmed to the required size and shape with surgical scissors. The use of sterile metallic foil as a stencil is possible. 3. The matrix should be used after wetting in sterile saline or the patient blood for 5 minutes, upon achieving the needed flexibility. Size and shape should match closely match the defect. 4. Due to the compact structure of this matrix, fixation or suturing is possible. After placement in covered sites, the mucoperiosteal flap should be sutured over the matrix without tension. The wound should, whenever possible, be completely closed to avoid rapid resorption. 5. Complete penetration of the Zenoss Matrix by blood allows close adaptation and adhesion of the matrix to the underlying surface. To avoid a bacterial contamination risk, minimize the contact of Zenoss Matrix with saliva or other media during the surgical stage. 6. During the healing phase stress in the wound area from prosthetic pressure or palpation should be avoided. Intensive mechanical oral hygiene should be replaced by antibacterial rinsing (e.g., with chlorhexidine) for the first 3 weeks. Antibiotic therapy is prescribed at the discretion of the clinician.
